Scientist investigating mutation link to breast cancer drug resistance

[News]

A leading scientist is investigating how oestrogen receptor (ER) mutations can cause drug resistance in secondary breast cancer patients receiving anti-hormone treatments such as tamoxifen.

More... (http://www.medicalnewstoday.com/releases/288204.php)